Barinthus Biotherapeutics (BRNS) Profit After Tax Growth (1y) (2021 - 2026)
Barinthus Biotherapeutics (BRNS) Profit After Tax Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | -88.68% |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 66.06% |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 17.05% |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -290.15% |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | -129.68% |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | -632.44% |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 59.59% |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Barinthus Biotherapeutics | 27.78 Mn | -39.33 Mn | - | 71.86% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 71.86% |
| Dec 31, 2025 | 45.86% |
| Sep 30, 2025 | -79.52% |
| Jun 30, 2025 | -24.69% |
| Mar 31, 2025 | -26.66% |
| Dec 31, 2024 | -18.78% |
| Sep 30, 2024 | 42.49% |
| Jun 30, 2024 | 28.88% |
| Mar 31, 2024 | 14.83% |
| Dec 31, 2023 | 18.39% |
| Sep 30, 2023 | -271.20% |
| Jun 30, 2023 | -251.85% |
| Mar 31, 2023 | -807.96% |
| Dec 31, 2022 | -39.67% |
| Sep 30, 2022 | 280.35% |
| Jun 30, 2022 | 198.15% |
| Mar 31, 2022 | 116.73% |
| Dec 31, 2021 | -44.14% |
| Sep 30, 2021 | -2,385.00% |
| Jun 30, 2021 | -337.11% |